nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Acetylsalicylic acid—TP53—colon cancer	0.0468	0.509	CrCbGaD
Nitazoxanide—Urine color abnormal—Capecitabine—colon cancer	0.0456	0.0502	CcSEcCtD
Nitazoxanide—Chromaturia—Capecitabine—colon cancer	0.0301	0.0331	CcSEcCtD
Nitazoxanide—Lung disorder—Irinotecan—colon cancer	0.0227	0.025	CcSEcCtD
Nitazoxanide—Leukocytosis—Fluorouracil—colon cancer	0.0163	0.018	CcSEcCtD
Nitazoxanide—Meloxicam—PTGS2—colon cancer	0.0159	0.173	CrCbGaD
Nitazoxanide—Metrorrhagia—Capecitabine—colon cancer	0.015	0.0165	CcSEcCtD
Nitazoxanide—Salsalate—PTGS2—colon cancer	0.0122	0.133	CrCbGaD
Nitazoxanide—Lung disorder—Methotrexate—colon cancer	0.0113	0.0124	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Irinotecan—colon cancer	0.0109	0.012	CcSEcCtD
Nitazoxanide—Dysuria—Vincristine—colon cancer	0.00966	0.0106	CcSEcCtD
Nitazoxanide—Acetylsalicylic acid—PTGS2—colon cancer	0.00915	0.0996	CrCbGaD
Nitazoxanide—Ear pain—Capecitabine—colon cancer	0.00913	0.0101	CcSEcCtD
Nitazoxanide—Increased appetite—Capecitabine—colon cancer	0.00829	0.00913	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Vincristine—colon cancer	0.00823	0.00906	CcSEcCtD
Nitazoxanide—Thirst—Capecitabine—colon cancer	0.00819	0.00902	CcSEcCtD
Nitazoxanide—Epistaxis—Fluorouracil—colon cancer	0.00811	0.00893	CcSEcCtD
Nitazoxanide—Rhinitis—Irinotecan—colon cancer	0.00808	0.00889	CcSEcCtD
Nitazoxanide—Acetylsalicylic acid—ABCB1—colon cancer	0.00778	0.0847	CrCbGaD
Nitazoxanide—Rhinitis—Fluorouracil—colon cancer	0.00773	0.00852	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Fluorouracil—colon cancer	0.00768	0.00845	CcSEcCtD
Nitazoxanide—Pharyngitis—Fluorouracil—colon cancer	0.00766	0.00843	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Capecitabine—colon cancer	0.0073	0.00804	CcSEcCtD
Nitazoxanide—Chills—Irinotecan—colon cancer	0.00723	0.00796	CcSEcCtD
Nitazoxanide—Back pain—Vincristine—colon cancer	0.00696	0.00767	CcSEcCtD
Nitazoxanide—Flatulence—Irinotecan—colon cancer	0.00691	0.00761	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00687	0.00757	CcSEcCtD
Nitazoxanide—Back pain—Irinotecan—colon cancer	0.00678	0.00747	CcSEcCtD
Nitazoxanide—Muscle spasms—Irinotecan—colon cancer	0.00674	0.00742	CcSEcCtD
Nitazoxanide—Influenza—Capecitabine—colon cancer	0.00674	0.00742	CcSEcCtD
Nitazoxanide—Anaemia—Vincristine—colon cancer	0.00665	0.00733	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Irinotecan—colon cancer	0.00651	0.00716	CcSEcCtD
Nitazoxanide—Anaemia—Irinotecan—colon cancer	0.00648	0.00714	CcSEcCtD
Nitazoxanide—Malaise—Irinotecan—colon cancer	0.00632	0.00696	CcSEcCtD
Nitazoxanide—Dysuria—Capecitabine—colon cancer	0.0063	0.00694	CcSEcCtD
Nitazoxanide—Syncope—Irinotecan—colon cancer	0.00629	0.00692	CcSEcCtD
Nitazoxanide—Hypertension—Vincristine—colon cancer	0.00622	0.00684	CcSEcCtD
Nitazoxanide—Anaemia—Fluorouracil—colon cancer	0.00621	0.00683	CcSEcCtD
Nitazoxanide—Loss of consciousness—Irinotecan—colon cancer	0.00616	0.00679	CcSEcCtD
Nitazoxanide—Myalgia—Vincristine—colon cancer	0.00613	0.00675	CcSEcCtD
Nitazoxanide—Hypertension—Irinotecan—colon cancer	0.00605	0.00667	CcSEcCtD
Nitazoxanide—Discomfort—Irinotecan—colon cancer	0.0059	0.00649	CcSEcCtD
Nitazoxanide—Oedema—Vincristine—colon cancer	0.00588	0.00647	CcSEcCtD
Nitazoxanide—Infection—Vincristine—colon cancer	0.00584	0.00643	CcSEcCtD
Nitazoxanide—Oedema—Irinotecan—colon cancer	0.00572	0.0063	CcSEcCtD
Nitazoxanide—Myalgia—Fluorouracil—colon cancer	0.00572	0.0063	CcSEcCtD
Nitazoxanide—Infection—Irinotecan—colon cancer	0.00569	0.00626	CcSEcCtD
Nitazoxanide—Epistaxis—Capecitabine—colon cancer	0.00566	0.00624	CcSEcCtD
Nitazoxanide—Discomfort—Fluorouracil—colon cancer	0.00565	0.00622	CcSEcCtD
Nitazoxanide—Shock—Irinotecan—colon cancer	0.00563	0.0062	CcSEcCtD
Nitazoxanide—Anorexia—Vincristine—colon cancer	0.0056	0.00617	CcSEcCtD
Nitazoxanide—Oedema—Fluorouracil—colon cancer	0.00548	0.00604	CcSEcCtD
Nitazoxanide—Anorexia—Irinotecan—colon cancer	0.00545	0.00601	CcSEcCtD
Nitazoxanide—Infection—Fluorouracil—colon cancer	0.00545	0.006	CcSEcCtD
Nitazoxanide—Rhinitis—Capecitabine—colon cancer	0.0054	0.00595	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Capecitabine—colon cancer	0.00536	0.00591	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Vincristine—colon cancer	0.00535	0.0059	CcSEcCtD
Nitazoxanide—Pharyngitis—Capecitabine—colon cancer	0.00535	0.00589	CcSEcCtD
Nitazoxanide—Tachycardia—Fluorouracil—colon cancer	0.00535	0.00589	CcSEcCtD
Nitazoxanide—Insomnia—Vincristine—colon cancer	0.00531	0.00585	CcSEcCtD
Nitazoxanide—Anorexia—Fluorouracil—colon cancer	0.00522	0.00575	CcSEcCtD
Nitazoxanide—Insomnia—Irinotecan—colon cancer	0.00518	0.0057	CcSEcCtD
Nitazoxanide—Decreased appetite—Vincristine—colon cancer	0.00511	0.00562	CcSEcCtD
Nitazoxanide—Somnolence—Irinotecan—colon cancer	0.00509	0.0056	CcSEcCtD
Nitazoxanide—Dyspepsia—Irinotecan—colon cancer	0.00504	0.00555	CcSEcCtD
Nitazoxanide—Constipation—Vincristine—colon cancer	0.00502	0.00553	CcSEcCtD
Nitazoxanide—Pain—Vincristine—colon cancer	0.00502	0.00553	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00499	0.0055	CcSEcCtD
Nitazoxanide—Decreased appetite—Irinotecan—colon cancer	0.00497	0.00548	CcSEcCtD
Nitazoxanide—Insomnia—Fluorouracil—colon cancer	0.00496	0.00546	CcSEcCtD
Nitazoxanide—Pain—Irinotecan—colon cancer	0.00489	0.00539	CcSEcCtD
Nitazoxanide—Constipation—Irinotecan—colon cancer	0.00489	0.00539	CcSEcCtD
Nitazoxanide—Somnolence—Fluorouracil—colon cancer	0.00487	0.00537	CcSEcCtD
Nitazoxanide—Chills—Capecitabine—colon cancer	0.00484	0.00533	CcSEcCtD
Nitazoxanide—Dyspepsia—Fluorouracil—colon cancer	0.00482	0.00531	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Vincristine—colon cancer	0.00481	0.00529	CcSEcCtD
Nitazoxanide—Decreased appetite—Fluorouracil—colon cancer	0.00476	0.00525	CcSEcCtD
Nitazoxanide—Feeling abnormal—Irinotecan—colon cancer	0.00472	0.00519	CcSEcCtD
Nitazoxanide—Dysuria—Methotrexate—colon cancer	0.00469	0.00516	CcSEcCtD
Nitazoxanide—Pain—Fluorouracil—colon cancer	0.00469	0.00516	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Irinotecan—colon cancer	0.00468	0.00515	CcSEcCtD
Nitazoxanide—Abdominal pain—Vincristine—colon cancer	0.00465	0.00512	CcSEcCtD
Nitazoxanide—Body temperature increased—Vincristine—colon cancer	0.00465	0.00512	CcSEcCtD
Nitazoxanide—Flatulence—Capecitabine—colon cancer	0.00462	0.00509	CcSEcCtD
Nitazoxanide—Back pain—Capecitabine—colon cancer	0.00454	0.005	CcSEcCtD
Nitazoxanide—Abdominal pain—Irinotecan—colon cancer	0.00452	0.00498	CcSEcCtD
Nitazoxanide—Body temperature increased—Irinotecan—colon cancer	0.00452	0.00498	CcSEcCtD
Nitazoxanide—Feeling abnormal—Fluorouracil—colon cancer	0.00452	0.00497	CcSEcCtD
Nitazoxanide—Muscle spasms—Capecitabine—colon cancer	0.00451	0.00497	CcSEcCtD
Nitazoxanide—Tremor—Capecitabine—colon cancer	0.0044	0.00484	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Capecitabine—colon cancer	0.00435	0.00479	CcSEcCtD
Nitazoxanide—Anaemia—Capecitabine—colon cancer	0.00434	0.00478	CcSEcCtD
Nitazoxanide—Body temperature increased—Fluorouracil—colon cancer	0.00433	0.00477	CcSEcCtD
Nitazoxanide—Hypersensitivity—Vincristine—colon cancer	0.00433	0.00477	CcSEcCtD
Nitazoxanide—Malaise—Capecitabine—colon cancer	0.00423	0.00466	CcSEcCtD
Nitazoxanide—Epistaxis—Methotrexate—colon cancer	0.00422	0.00464	CcSEcCtD
Nitazoxanide—Hypersensitivity—Irinotecan—colon cancer	0.00422	0.00464	CcSEcCtD
Nitazoxanide—Asthenia—Vincristine—colon cancer	0.00422	0.00464	CcSEcCtD
Nitazoxanide—Syncope—Capecitabine—colon cancer	0.00421	0.00463	CcSEcCtD
Nitazoxanide—Loss of consciousness—Capecitabine—colon cancer	0.00412	0.00454	CcSEcCtD
Nitazoxanide—Asthenia—Irinotecan—colon cancer	0.00411	0.00452	CcSEcCtD
Nitazoxanide—Hypertension—Capecitabine—colon cancer	0.00405	0.00446	CcSEcCtD
Nitazoxanide—Hypersensitivity—Fluorouracil—colon cancer	0.00404	0.00445	CcSEcCtD
Nitazoxanide—Diarrhoea—Vincristine—colon cancer	0.00402	0.00443	CcSEcCtD
Nitazoxanide—Myalgia—Capecitabine—colon cancer	0.004	0.0044	CcSEcCtD
Nitazoxanide—Pharyngitis—Methotrexate—colon cancer	0.00398	0.00439	CcSEcCtD
Nitazoxanide—Discomfort—Capecitabine—colon cancer	0.00395	0.00435	CcSEcCtD
Nitazoxanide—Diarrhoea—Irinotecan—colon cancer	0.00392	0.00431	CcSEcCtD
Nitazoxanide—Dry mouth—Capecitabine—colon cancer	0.00391	0.0043	CcSEcCtD
Nitazoxanide—Dizziness—Vincristine—colon cancer	0.00389	0.00428	CcSEcCtD
Nitazoxanide—Pruritus—Fluorouracil—colon cancer	0.00388	0.00427	CcSEcCtD
Nitazoxanide—Oedema—Capecitabine—colon cancer	0.00383	0.00422	CcSEcCtD
Nitazoxanide—Infection—Capecitabine—colon cancer	0.00381	0.00419	CcSEcCtD
Nitazoxanide—Dizziness—Irinotecan—colon cancer	0.00378	0.00417	CcSEcCtD
Nitazoxanide—Shock—Capecitabine—colon cancer	0.00377	0.00415	CcSEcCtD
Nitazoxanide—Diarrhoea—Fluorouracil—colon cancer	0.00375	0.00413	CcSEcCtD
Nitazoxanide—Tachycardia—Capecitabine—colon cancer	0.00374	0.00412	CcSEcCtD
Nitazoxanide—Vomiting—Vincristine—colon cancer	0.00374	0.00411	CcSEcCtD
Nitazoxanide—Rash—Vincristine—colon cancer	0.0037	0.00408	CcSEcCtD
Nitazoxanide—Dermatitis—Vincristine—colon cancer	0.0037	0.00408	CcSEcCtD
Nitazoxanide—Headache—Vincristine—colon cancer	0.00368	0.00405	CcSEcCtD
Nitazoxanide—Anorexia—Capecitabine—colon cancer	0.00365	0.00402	CcSEcCtD
Nitazoxanide—Vomiting—Irinotecan—colon cancer	0.00364	0.00401	CcSEcCtD
Nitazoxanide—Dizziness—Fluorouracil—colon cancer	0.00362	0.00399	CcSEcCtD
Nitazoxanide—Rash—Irinotecan—colon cancer	0.00361	0.00397	CcSEcCtD
Nitazoxanide—Dermatitis—Irinotecan—colon cancer	0.0036	0.00397	CcSEcCtD
Nitazoxanide—Chills—Methotrexate—colon cancer	0.0036	0.00397	CcSEcCtD
Nitazoxanide—Headache—Irinotecan—colon cancer	0.00359	0.00395	CcSEcCtD
Nitazoxanide—Nausea—Vincristine—colon cancer	0.00349	0.00384	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00349	0.00384	CcSEcCtD
Nitazoxanide—Vomiting—Fluorouracil—colon cancer	0.00348	0.00384	CcSEcCtD
Nitazoxanide—Insomnia—Capecitabine—colon cancer	0.00346	0.00381	CcSEcCtD
Nitazoxanide—Rash—Fluorouracil—colon cancer	0.00346	0.00381	CcSEcCtD
Nitazoxanide—Dermatitis—Fluorouracil—colon cancer	0.00345	0.0038	CcSEcCtD
Nitazoxanide—Headache—Fluorouracil—colon cancer	0.00343	0.00378	CcSEcCtD
Nitazoxanide—Nausea—Irinotecan—colon cancer	0.0034	0.00374	CcSEcCtD
Nitazoxanide—Back pain—Methotrexate—colon cancer	0.00338	0.00372	CcSEcCtD
Nitazoxanide—Dyspepsia—Capecitabine—colon cancer	0.00337	0.00371	CcSEcCtD
Nitazoxanide—Decreased appetite—Capecitabine—colon cancer	0.00333	0.00367	CcSEcCtD
Nitazoxanide—Pain—Capecitabine—colon cancer	0.00328	0.00361	CcSEcCtD
Nitazoxanide—Constipation—Capecitabine—colon cancer	0.00328	0.00361	CcSEcCtD
Nitazoxanide—Nausea—Fluorouracil—colon cancer	0.00326	0.00358	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Methotrexate—colon cancer	0.00324	0.00357	CcSEcCtD
Nitazoxanide—Anaemia—Methotrexate—colon cancer	0.00323	0.00356	CcSEcCtD
Nitazoxanide—Feeling abnormal—Capecitabine—colon cancer	0.00316	0.00348	CcSEcCtD
Nitazoxanide—Malaise—Methotrexate—colon cancer	0.00315	0.00347	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Capecitabine—colon cancer	0.00313	0.00345	CcSEcCtD
Nitazoxanide—Body temperature increased—Capecitabine—colon cancer	0.00303	0.00333	CcSEcCtD
Nitazoxanide—Abdominal pain—Capecitabine—colon cancer	0.00303	0.00333	CcSEcCtD
Nitazoxanide—Myalgia—Methotrexate—colon cancer	0.00297	0.00328	CcSEcCtD
Nitazoxanide—Discomfort—Methotrexate—colon cancer	0.00294	0.00324	CcSEcCtD
Nitazoxanide—Infection—Methotrexate—colon cancer	0.00283	0.00312	CcSEcCtD
Nitazoxanide—Hypersensitivity—Capecitabine—colon cancer	0.00282	0.00311	CcSEcCtD
Nitazoxanide—Asthenia—Capecitabine—colon cancer	0.00275	0.00303	CcSEcCtD
Nitazoxanide—Anorexia—Methotrexate—colon cancer	0.00272	0.00299	CcSEcCtD
Nitazoxanide—Pruritus—Capecitabine—colon cancer	0.00271	0.00298	CcSEcCtD
Nitazoxanide—Diarrhoea—Capecitabine—colon cancer	0.00262	0.00289	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.0026	0.00286	CcSEcCtD
Nitazoxanide—Insomnia—Methotrexate—colon cancer	0.00258	0.00284	CcSEcCtD
Nitazoxanide—Somnolence—Methotrexate—colon cancer	0.00253	0.00279	CcSEcCtD
Nitazoxanide—Dizziness—Capecitabine—colon cancer	0.00253	0.00279	CcSEcCtD
Nitazoxanide—Dyspepsia—Methotrexate—colon cancer	0.00251	0.00276	CcSEcCtD
Nitazoxanide—Decreased appetite—Methotrexate—colon cancer	0.00248	0.00273	CcSEcCtD
Nitazoxanide—Pain—Methotrexate—colon cancer	0.00244	0.00268	CcSEcCtD
Nitazoxanide—Vomiting—Capecitabine—colon cancer	0.00244	0.00268	CcSEcCtD
Nitazoxanide—Rash—Capecitabine—colon cancer	0.00241	0.00266	CcSEcCtD
Nitazoxanide—Dermatitis—Capecitabine—colon cancer	0.00241	0.00266	CcSEcCtD
Nitazoxanide—Headache—Capecitabine—colon cancer	0.0024	0.00264	CcSEcCtD
Nitazoxanide—Feeling abnormal—Methotrexate—colon cancer	0.00235	0.00259	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Methotrexate—colon cancer	0.00233	0.00257	CcSEcCtD
Nitazoxanide—Nausea—Capecitabine—colon cancer	0.00227	0.00251	CcSEcCtD
Nitazoxanide—Abdominal pain—Methotrexate—colon cancer	0.00225	0.00248	CcSEcCtD
Nitazoxanide—Body temperature increased—Methotrexate—colon cancer	0.00225	0.00248	CcSEcCtD
Nitazoxanide—Hypersensitivity—Methotrexate—colon cancer	0.0021	0.00231	CcSEcCtD
Nitazoxanide—Asthenia—Methotrexate—colon cancer	0.00205	0.00225	CcSEcCtD
Nitazoxanide—Pruritus—Methotrexate—colon cancer	0.00202	0.00222	CcSEcCtD
Nitazoxanide—Diarrhoea—Methotrexate—colon cancer	0.00195	0.00215	CcSEcCtD
Nitazoxanide—Dizziness—Methotrexate—colon cancer	0.00189	0.00208	CcSEcCtD
Nitazoxanide—Vomiting—Methotrexate—colon cancer	0.00181	0.002	CcSEcCtD
Nitazoxanide—Rash—Methotrexate—colon cancer	0.0018	0.00198	CcSEcCtD
Nitazoxanide—Dermatitis—Methotrexate—colon cancer	0.0018	0.00198	CcSEcCtD
Nitazoxanide—Headache—Methotrexate—colon cancer	0.00179	0.00197	CcSEcCtD
Nitazoxanide—Nausea—Methotrexate—colon cancer	0.00169	0.00186	CcSEcCtD
